Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually.
Catalent’s Philadelphia site serves as a center for the company’s clinical supply services and oral solid dose development and manufacturing. The site specializes in providing comprehensive solutions for clinical trial materials, including packaging, labeling, and distribution. Catalent’s Philadelphia site also offers expertise in oral solid dose formulation development, analytical testing, and commercial-scale manufacturing. The facility is equipped with advanced technology and adheres to stringent quality and regulatory standards to ensure the production of high-quality products. It plays a crucial role in supporting the pharmaceutical industry by providing efficient and reliable services for clinical supply and oral solid dose development and manufacturing.